title: Can neridronate be effective in the treatment of osteoporosis in hypogonadic men?
authors.forename: G
authors.initials: G
authors.lastname: Saviola
authors.forename: L
authors.initials: L
authors.lastname: Abdi Ali
authors.forename: S
authors.initials: S
authors.lastname: Shams Eddin
authors.forename: M
authors.initials: M
authors.lastname: Manfredi
authors.forename: M
authors.initials: M
authors.lastname: Benucci
mesh_terms: D015502:Absorptiometry, Photon; D015519:Bone Density / Q000502:physiology; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007006:Hypogonadism / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D004164:Diphosphonates; C053389:6-amino-1-hydroxyhexane-1,1-diphosphonate